Paul Brennan

Professor of Medicinal Chemistry and head of chemistry of the Alzheimer’s Research UK Oxford Drug Discovery Institute in the Centre for Medicines Discovery at the University of Oxford

Worked for Amgen developing kinase inhibitors for oncology and at Pfizer as medicinal chemistry design lead

Post-doctoral fellowship at University of Cambridge, PhD from UC Berkeley (Medicinal Chemistry), undergraduate degree from UC Davis